Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIM.L Regulatory News (SIM)

  • There is currently no data for SIM

Exercise of Options

14 Mar 2019 07:00

RNS Number : 8111S
SimiGon Limited
14 March 2019
 

 

14 March 2019

 

SimiGon Ltd

 

("SimiGon" or the "Company")

 

Exercise of Options

 

SimiGon Limited (LSE: SIM), a global leader in providing simulation training solutions, announces that application has been made for 5,000 new ordinary shares of 0.01 NIS each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued pursuant to the exercise of options by a former employee. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares and Admission is expected to become effective on 19 March, 2019.

 

Following this issue of new Ordinary Shares, the Company will have 51,399,189 Ordinary Shares in issue. The Company holds a total of 535,571 Ordinary Shares in treasury. Accordingly, the total number of voting rights in the Company will be 50,868,618.

 

 

 

Enquiries:

 

SimiGon Ltd

Ami Vizer, Chief Executive Officer

+1 (407) 951 5548

Efi Manea, Chief Financial Officer

finnCap (NOMAD & Broker)

+44 (0) 20 7220 0500

Scott Mathieson / Matthew Radley (corporate finance)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBXLLFKXFEBBQ
Date   Source Headline
2nd Aug 20193:36 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSDirectorate Changes
25th Jul 20197:00 amRNSContract Win
18th Jul 20197:00 amRNSContract Win
28th Jun 20197:00 amRNSPosting of Annual Report and Accounts
29th Apr 20197:00 amRNSSimigon kick off reseach programme with the IAF
29th Apr 20197:00 amRNSFinal Results
24th Apr 20197:00 amRNSUSAF logistics support contract extension
18th Apr 20197:00 amRNSSimigon signs BPA with the US DoD
14th Mar 20197:00 amRNSExercise of Options
14th Feb 20197:00 amRNSContract Win
14th Feb 20197:00 amRNSTrading Update
19th Dec 20187:00 amRNSContract Win
7th Dec 20185:15 pmRNSResult of AGM
2nd Nov 201812:30 pmRNSNotice of AGM
15th Oct 20187:00 amRNSFurther Contract
12th Oct 20186:00 pmRNSTransaction in Own Shares-Replacement
10th Oct 20186:21 pmRNSTransaction in Own Shares
8th Oct 20187:00 amRNSContract Win
26th Sep 20187:00 amRNSContract Win
24th Sep 20187:00 amRNSHalf-year Report
7th Sep 20184:25 pmRNSTransaction in Own Shares
17th Aug 20181:40 pmRNSTransaction in Own Shares
26th Jun 20182:26 pmRNSPosting of Annual Report and Accounts
21st Jun 20188:00 amRNSFurther Contract
6th Jun 20187:00 amRNSTransaction in Own Shares
8th May 20187:00 amRNSUSAF technician training contract
23rd Apr 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSAppointment to the Board
5th Mar 20187:00 amRNSTransaction in Own Shares
19th Feb 20187:00 amRNSContract win
7th Feb 20187:00 amRNSSimiGon awarded additional USAF support contract
16th Jan 20187:00 amRNSTrading Update
13th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSShare buyback programme
17th Nov 20177:00 amRNSUpdate on Strategic Contract
25th Sep 20177:00 amRNSInterim Results
8th Sep 20172:48 pmRNSResult of AGM
4th Sep 20177:00 amRNSSimiGon secures FAA contract for UAS simulation
23rd Aug 20177:00 amRNSNotice of Results
4th Aug 201711:35 amRNSNotice of AGM
2nd Aug 20172:35 pmRNSHolding(s) in Company
28th Jul 20177:00 amRNSTrading Update
5th Jul 20177:00 amRNSCompletion of milestones for US$6.7m contract
14th Jun 20177:00 amRNSPosting of Annual Report and Accounts
11th Apr 20177:00 amRNSFinal Results
16th Feb 20177:00 amRNSTrading Statement
29th Dec 20163:12 pmRNSResult of AGM
24th Nov 20162:18 pmRNSNotice of AGM
5th Oct 20167:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.